Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages

  Hani, El Habib ^a   Stoffers, Doris A ^b,c   Chèvre, Jean Claude ^a   Durand, Emmanuelle ^a   Stanojevic, Violeta ^b   Dina, Christian ^a   Habener, Joel F ^b   Froguel, Philippe ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HORMONE ACTION; HUMAN; INSULIN SYNTHESIS; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0032718689     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7469     Document Type: Article

References (25)

1. DeFronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabet. Ref. 5:177-269.
2. Hanis, C.L., et al. 1996. A genome-wide search for human non-insulin-dependent (type2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 13:161-166.
3. Mahtani, M.M., et al. 1996. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat. Genet. 14:90-94.
4. Pratley, R.E., et al. 1998. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J. Clin. Invest. 101:1757-1764,
5. Hattersley, A.T. 1998. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet. Med. 15:15-24.
6. Froguel, P., et al. 1993. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328:697-702.
7. Yamagata, K., et al. 1996. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature. 384:458-460.
8. Yamagata, K., et al. 1996. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature. 384:455-458.
9. Stoffers, D.A., Ferrer, J., Clarke, W.L., and Habener J.F. 1997. Early onset type II diabetes (MODY4) linked to IPF1. Nat. Genet. 17:138-139.
10. Horikawa, Y., et al. 1997. Mutation in hepatocyte nuclear factor-1 gene (TCF2) associated with MODY. Nat. Genet. 17:384-385.
11. Habener, J.F., and Stoffers, D.A. 1998. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc. Assoc. Am. Phys. 110:12-21.
12. Jonsson, J., Carlsson, L., Edlund, T., and Edlund, H. 1994. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 371:606-609.
13. Ahlgren, U., Jonsson, J., and Edlund, H. 1996. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development. 122:1409-1416.
14. Stoffers, D.A., Zinkin, N.T., Stanojevic, V., Clarke, W.L., and Habener, J.F. 1997. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15:106-110.
15. Stoffers, D.A., Stanojevic, V., and Habener, J.F. 1998. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprorein. J. Clin. Invest. 102:232-241.
16. Vionnet, N., et al. 1997. Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes. 46:1062-1068.
17. Hani, E.H., et al. 1998. A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J. Clin. Invest. 101:521-526.
18. Chevre, J.C., Hani, E.H., Stoffers, D.A., Habener, J.F., and Froguel, P. 1998. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes. 47:843-844.
19. Byrne, M.M., et al. 1995. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes. 44:699-704.
20. Lu, M., Miller, C., and Habener, J.F. 1996. Functional regions of the homeodomain protein IDX-1 required for transactivation of the rat somatostatin gene. Endocrinology. 137:2959-2967.
21. Mermod, N., O'Neill, E.A., Kelly, T.J., and Tjian, R. 1989. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell. 58:741-753.
22. Gerber, H.P., et al. 1994. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science. 263:808-811.
23. Peshavaria, M., Henderson, E., Sharma, A., Wright, C.V., and Stein, R. 1997. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol. Cell. Biol. 17:3987-3996.
24. Dutta, S., Bonner-Weir, S., Montminy, M., and Wright, C.V. 1998. Regulatory factor linked to late-onset diabetes? Nature. 392:560.
25. Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K., and Edlund, H. 1998. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12:1763-1768.